Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Channel Medsystems secures $30 million in Series C financing led by InnovaHealth Partners to accelerate commercial expansion of Cerene®.
PRIVATEAug 20, 2026•about 4 hours ago
Amount Raised
$30 Million
Round Type
Series C
BerkeleyHealthcareHealth Care
Investors
Innova Health Partners, Lp
Description
Channel Medsystems has reached $30 million in its ongoing Series C financing, led by InnovaHealth Partners. The funding will expand its commercial organization, increase awareness, and support clinical evidence generation for Cerene®. This investment reflects increasing investor confidence in the updated commercial strategy. Channel Medsystems aims to enhance access to its treatment for women suffering from heavy menstrual bleeding and dysmenorrhea.
Company Information
Company
Channel Medsystems
Location
2919 7th Street
Berkeley, California, United States
About
Channel Medsystems is a privately held company dedicated to transforming women’s healthcare globally through the development and commercialization of its flagship product, the Cerene® Cryotherapy Device. Cerene is a non-hormonal, incision-free treatment designed to provide safe, effective, and convenient therapy for women suffering from heavy menstrual bleeding (HMB) and dysmenorrhea. Offering a modern alternative to invasive surgery or long-term medications, Channel Medsystems is committed to improving patient outcomes, broadening access, and empowering women with greater control over their care.
Don't miss Channel Medsystems's next move
Get an email the moment Channel Medsystems raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Related People
Suggested for you
3 contacts
Predictive Intelligence
Strategic
ML-powered predictions for Channel Medsystems's next move